.Ascendis Pharma has become a prospective risk to BioMarin's Voxzogo, disclosing phase 3 growth cond...
.Though Alkeus Pharmaceuticals' oral eye ailment possession fell short to substantially lower geogra...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually easy to miss a smaller...
.Immune system checkpoint preventions are actually the superheroes of cancer cells treatment. Medica...
.Accept to this week's Chutes & Ladders, our summary of significant management hirings, shootings...
.Regeneron is actually back along with lasting follow-up for its own LAG-3 inhibitor as well as PD-1...
.AstraZeneca has actually shared an early examine the functionality of its own in-house antibody-dru...
.After introducing a period 3 launch based on good midstage outcomes, iTeos and also GSK are actuall...
.The FDA ought to be more available and collective to let loose a surge in commendations of uncommon...
.It is actually an abnormally occupied Friday for biotech IPOs, with Zenas BioPharma, MBX as well as...